Services SUPPORT Online inquiry

For Research Use Only. Not For Clinical Use.

Contact us
  • Email:

Neuronal Cells Differentiation from iPSC

Creative Biolabs offers the most advanced and comprehensive iPSC services for our customers all over the world. With years of experience, scientists at Creative Biolabs now are able to generate the neuronal cells via our iPSC differentiation technology.

Introduction of iPSC-derived Neuronal Cells

With the unlimited proliferative capacity and extensive differentiation potential, human pluripotent stem cells (hPSCs) present distinct advantages than adult stem cells. In order to avoid the ethical issues, the application of human embryonic stem cell (hES cells) is replaced by human induced pluripotent stem cells (hiPSCs). which can be generated from various adult somatic cell types via the introduction of four specific transcription factors: OCT3/4, SOX2, KLF4, and c-MYC. However, these hiPSCs cannot be used directly into patients because of the tumorigenic potential. In this case, a differentiation protocol is an essential prerequisite to direct hiPSCs into specific cell types. As such, the neural differentiation of hiPSCs enables a promising cell source for both regenerative medicine and cell therapy.

Neuronal cells immunostaining after two weeks of differentiation.Fig.1 Neuronal cells immunostaining after two weeks of differentiation.

Neural Differentiation of hiPSCs

The neuronal cell differentiation from iPSC offers great promise to both basic research and clinical applications. Previously, the traditional technologies utilized to initiate neural differentiation of hiPSCs are embryoid body formation and co-cultivation with stromal cell lines. However, there are a series of disadvantages, including time-consuming preparation, low efficiency, complicated process, and variability results, largely limit their applications. In this case, now Creative Biolabs has built the high-efficient neural differentiation method based on chemically defined culture milieu and small molecular inducers. The principle of our protocol relies on the interplay of activation and inhibition of multiple developmental signaling pathways. The small molecules enable the modulation of the key developmental signaling pathways thus regulate neural differentiation of hiPSCs. Now we focus on directing hiPSCs into four major specific neuronal sublineages which are serotonergic, cholinergic/motor, dopaminergic, and serotonergic neurons. In summary, we are able to get various neuronal cell types based on our special synthetic small molecules, and more specifically potent small molecules are under development for precise control of neurogenesis.

The generation of neurons from hiPSCs.Fig.2 The generation of neurons from hiPSCs.

Features of Small Molecules

  • Cost effective.
  • Stable and reduce experimental variability.
  • Rapid, reversible, and tuneable biological effects.

Applications of iPSC-derived Neuronal Cells

  • In vitro study for neural development and neurological diseases mechanisms.
  • Drug development, screening, and toxicology assays.
  • Therapeutic targets identification.
  • In vitro modeling of human neurological diseases.
  • Autologous cell sources for therapy of various neurological diseases.
  • Autologous cell therapy for regenerative medicine.

With our well-established iPSC differentiation technology, Creative Biolabs now can generate iPSC-derived neuronal cells for our clients. Based on our extensive experience and advanced platform, our service is built to meet the customer's project and specific requirements. Creative Biolabs also provide other services regarding iPSC differentiation, please feel free to contact us if you are interested in them.

Reference

  1. Yap, M.S. (2015). “Neural differentiation of human pluripotent stem cells for nontherapeutic applications: toxicology, pharmacology, and in vitro disease modeling.” Stem Cells International 2015, 105172.

For Research Use Only. Not For Clinical Use.